U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06972888) titled 'A Phase II Clinical Study of AC-201 Tablets in Subjects With Moderate-to-severe Plaque Psoriasis' on May 07.
Brief Summary: The purpose of the study is to evaluate the efficacy and safety of AC-201 tablets compared with placebo in subjects with moderate-to-severe plaque psoriasis
Study Start Date: April 23, 2024
Study Type: INTERVENTIONAL
Condition:
Plaque Psoriasis
Intervention:
DRUG: AC-201
AC-201 tablets will be administered orally
DRUG: Placebo
Matching placebo tablets will be administered orally.
Recruitment Status: COMPLETED
Sponsor: Accro Bioscience (Suzhou) Limited
Published by HT Digital Content Services with per...